Processa Pharmaceuticals, Inc.

PCSA·NASDAQ·$2.50Share Price as of 11/2·$6MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/07/26 10-K/AFY 202504/30/26 10-KFY 202503/18/26 10-QQ3 ended 09/30/2511/06/25

Disclosures

8-KCurrent report10/29/26 8-K/ACurrent report (amended)10/05/26 8-KCurrent report08/04/26 8-KCurrent report07/29/26 8-KCurrent report04/30/26

Prospectuses and Registrations

S-3Shelf registration10/09/26 S-8Registration of securities for employees09/22/25 424B5Prospectus supplement07/25/25 424B4Prospectus06/18/25 S-1Registration statement (IPO)06/13/25

Proxies

DEF 14ADefinitive proxy10/22/26 PRE 14APreliminary proxy10/09/26 PRE 14APreliminary proxy10/09/26 DEF 14ADefinitive proxy06/18/26 DEFA14AAdditional proxy materials08/25/25

Ownership

SC 13GBeneficial ownership08/18/26 Form 4Insider transaction08/11/26 Form 3Initial insider ownership07/30/26 Form 4Insider transaction07/30/26 Form 4Insider transaction07/28/26

Other

EFFECTRequest for effectiveness10/23/26 UPLOADLetter from the SEC08/13/25 CORRESPCorrespondence with the SEC08/08/25 UPLOADLetter from the SEC08/06/25 EFFECTRequest for effectiveness06/17/25